These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9156246

  • 1. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Bönig H, Göbel U, Zintl F, Burdach S.
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [Abstract] [Full Text] [Related]

  • 2. Humoral immunodeficiency in patients after bone marrow transplantation.
    Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Mauz-Körholz C, Zintl F, Burdach S.
    Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382
    [Abstract] [Full Text] [Related]

  • 3. [Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation].
    Körholz D, Hempel L, Packeisen J, Kunst D, Zintl F, Burdach S.
    Klin Padiatr; 1996 Dec; 208(4):141-4. PubMed ID: 8926680
    [Abstract] [Full Text] [Related]

  • 4. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
    Yabe M, Yabe H, Hattori K, Shimizu T, Matsumoto M, Morimoto T, Yasuda Y, Inoue H, Kato S, Nishimura T.
    Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
    [Abstract] [Full Text] [Related]

  • 5. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A, Salooja N, Russell-Jones R.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [Abstract] [Full Text] [Related]

  • 6. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
    Sanna A, Huang YM, Arru G, Fois ML, Link H, Rosati G, Sotgiu S.
    Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
    [Abstract] [Full Text] [Related]

  • 8. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T, Tanaka J, Fujii Y, Kobayashi M, Kasai M.
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [Abstract] [Full Text] [Related]

  • 9. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J, Imamura M, Kasai M, Zhu X, Kobayashi S, Imai K, Hashino S, Higa T, Sakurada K, Miyazaki T.
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [Abstract] [Full Text] [Related]

  • 10. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX, Jun CY, Yu ZX.
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [Abstract] [Full Text] [Related]

  • 11. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [Abstract] [Full Text] [Related]

  • 12. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y.
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [Abstract] [Full Text] [Related]

  • 13. IL-4-producing CD8(+) T cells may be an immunological hallmark of chronic GVHD.
    Nakamura K, Amakawa R, Takebayashi M, Son Y, Miyaji M, Tajima K, Nakai K, Ito T, Matsumoto N, Zen K, Kishimoto Y, Fukuhara S.
    Bone Marrow Transplant; 2005 Oct; 36(7):639-47. PubMed ID: 16044136
    [Abstract] [Full Text] [Related]

  • 14. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H, Dilloo D, Laws HJ, Zessack N, Heyll A, Burdach S.
    Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
    [Abstract] [Full Text] [Related]

  • 15. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD.
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

  • 17. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A, Barak V, Novick D, Nagler A.
    Cytokines Cell Mol Ther; 1997 Sep 15; 3(3):153-8. PubMed ID: 9426973
    [Abstract] [Full Text] [Related]

  • 18. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May 15; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 20. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
    Aswald JM, Lipton JH, Messner HA.
    Cytokines Cell Mol Ther; 2002 Dec 15; 7(2):75-82. PubMed ID: 12607798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.